您要查找的是不是:
- Acute thrombolytic therapy 院前
- Impact Thrombolytic Therapy of Acute Cerebral Infarction with Urokinase. 尿激酶冲击溶栓治疗急性脑梗塞。
- Objective To study the efficacy and safety of intravenous and intra-arterial thrombolytic therapy in acute cerebral infarction(ACI). 目的观察动脉溶栓与静脉溶栓治疗急性脑梗死(ACI)的疗效和安全性。
- Thrombolytic therapy of acute MVT with Urokinase and Batroxobin is feasible,effective and safe. 尿激酶联合巴曲酶治疗MVT是有效和安全的。
- Aggressive mechanical clot disruption: A safe adjunct to thrombolytic therapy in acute stroke? 强力机械性血块破碎是否是急性卒中溶栓治疗的安全辅助措施?
- Objective:To evaluate the clinical efficacy of intravenous thrombolytic therapy on acute myocardial infarction (AMI). 目的:评价早期静脉溶栓治疗急性心肌梗塞(AMI)的临床疗效。
- Especially in patients considered for thrombolytic therapy in acute stroke further diagnostics is essential. 尤其是患有急性卒中准备进行溶栓治疗的患者中,进一步确证尤为必要。
- Thrombolytic therapy is administered in the hospital. 溶血疗法一般由医院来执行。
- Conclusion: Intra arterial thrombolytic therapy started early is significantly effective in reducing the extent and degree of acute embolic infarction. 结论:早期经动脉溶栓治疗在减轻急性脑梗塞损伤范围和程度上效果显著;
- Objective It is to study the curative effect and saf ety of thrombolytic therapy on senile acute pulmonary-thrombo-embolism (PTE). 目的 研究老年急性肺血栓栓塞症 (PTE)溶栓治疗的疗效和安全性。
- Objective To study a new thrombolytic therapy of acute cere bral infarction by combined use of urokinase(UK) and protaglandin E 1(PGE 1). 目的 研究探索联合溶栓剂尿激酶 (Urokinase ,UK)和前列腺素E1(ProtaglandinE1,PGE1)对急性脑梗死患者进行静脉溶栓的临床疗效观察。
- Objective: To observe the efficacy of intravenous thrombolytic therapy of streptokinase on early acute myocardial infarction (AMI). 摘要目的:探讨链激酶静脉溶栓治疗急性心肌梗死的疗效。
- Intervention F: Is the Effectiveness and Safety of Thrombolytic Therapy for Adults with Acute Ischemic Stroke Affected by Time From Onset to Treatment? 发病到治疗的时间是否会影响急性缺血性卒中患者溶栓治疗的有效性和安全性?
- Objective:To study effects of patients with acute myocardial infarction(AMI) after thrombolytic therapy but without reperfusion. 目的:探讨急性心肌梗死(AMI)患者静脉溶栓治疗冠脉未通者的效果。
- Objective To evaluate intra-artery transcatheter thrombolytic therapy for the treatment of acute lower extremity deep vein thrombosis (LEDVT). 摘要目的评价动脉置管持续溶栓治疗急性下肢深静脉血栓形成(LEDVT)的效果。
- OBJECTIVE To observe the different efficacy with intravenous thrombolytic therapy between women and men after acute myocardical infarction. 目的探讨静脉溶栓对男女急性心肌梗塞患者的疗效对比。
- Conclusion Endovascular thrombolytic therapy with urokinase was a new effective treatment for acute cerebral infarction. 结论血管内介入、动脉尿激酶溶栓治疗,为急性脑梗死提供了一种新的有效治疗方法。
- Thrombi causing the acute cerebral infarction were detected on noncontrast CT in 40 of the 51 patients and 34 of the 40 received thrombolytic therapy. 51位患者中有41人经上述检查证实为血栓引起的急性脑梗塞,其中34人进行了溶栓治疗。
- The thrombolytic therapy in time windows can significantly improve the clinical outcome of patients with acute ischemic stroke. 及时有效的溶栓治疗能显著改善急性缺血性脑卒中患者的临床预后。
- As compared with thrombolytic therapy in the management of acute MI, mortality and nonfatal MI rates typically are considerably lower for primary PTCA. 与溶栓治疗相比,急性心肌梗死时采用PTCA治疗,患者的死亡率和非致死性心肌梗死的发生率明显降低。